Workshop on monounsaturated fatty acids

Scott M Grundy, A. Bonanome

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Monounsaturated fatty acids appear to have many advantages for a cholesterol-lowering diet. They will reduce the plasma LDL level when substituted for saturated fatty acids, and at the same time they will not raise the triglyceride level nor lower the HDL-cholesterol level. Their presence in the diet can enhance palatability for many people. Their value further is supported by their widespread use in the Mediterranean region, where large quantities of olive oil are consumed; in this region, rates of CHD are relatively low, and morbidity and mortality from other causes apparently are not increased. In laboratory animals, monounsaturates seemingly do not suppress the immune system or promote oncogenesis. Still, from the discussion of this colloquium, it was apparent that many questions remain unanswered about the metabolic actions of monounsaturated fatty acids, particularly as they compare with other cholesterol-lowering nutrients, and the exchange of ideas among the investigators should stimulate further research on thje metabolic effects of monounsaturated fatty acids.

Original languageEnglish (US)
Pages (from-to)644-648
Number of pages5
JournalArteriosclerosis
Volume7
Issue number6
StatePublished - 1987

Fingerprint

Monounsaturated Fatty Acids
Education
Cholesterol
Diet
Mediterranean Region
Laboratory Animals
HDL Cholesterol
Immune System
Carcinogenesis
Triglycerides
Fatty Acids
Research Personnel
Morbidity
Food
Mortality
Research

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Workshop on monounsaturated fatty acids. / Grundy, Scott M; Bonanome, A.

In: Arteriosclerosis, Vol. 7, No. 6, 1987, p. 644-648.

Research output: Contribution to journalArticle

Grundy, SM & Bonanome, A 1987, 'Workshop on monounsaturated fatty acids', Arteriosclerosis, vol. 7, no. 6, pp. 644-648.
Grundy, Scott M ; Bonanome, A. / Workshop on monounsaturated fatty acids. In: Arteriosclerosis. 1987 ; Vol. 7, No. 6. pp. 644-648.
@article{14323a8029ac43fe9d06587fd495abad,
title = "Workshop on monounsaturated fatty acids",
abstract = "Monounsaturated fatty acids appear to have many advantages for a cholesterol-lowering diet. They will reduce the plasma LDL level when substituted for saturated fatty acids, and at the same time they will not raise the triglyceride level nor lower the HDL-cholesterol level. Their presence in the diet can enhance palatability for many people. Their value further is supported by their widespread use in the Mediterranean region, where large quantities of olive oil are consumed; in this region, rates of CHD are relatively low, and morbidity and mortality from other causes apparently are not increased. In laboratory animals, monounsaturates seemingly do not suppress the immune system or promote oncogenesis. Still, from the discussion of this colloquium, it was apparent that many questions remain unanswered about the metabolic actions of monounsaturated fatty acids, particularly as they compare with other cholesterol-lowering nutrients, and the exchange of ideas among the investigators should stimulate further research on thje metabolic effects of monounsaturated fatty acids.",
author = "Grundy, {Scott M} and A. Bonanome",
year = "1987",
language = "English (US)",
volume = "7",
pages = "644--648",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Workshop on monounsaturated fatty acids

AU - Grundy, Scott M

AU - Bonanome, A.

PY - 1987

Y1 - 1987

N2 - Monounsaturated fatty acids appear to have many advantages for a cholesterol-lowering diet. They will reduce the plasma LDL level when substituted for saturated fatty acids, and at the same time they will not raise the triglyceride level nor lower the HDL-cholesterol level. Their presence in the diet can enhance palatability for many people. Their value further is supported by their widespread use in the Mediterranean region, where large quantities of olive oil are consumed; in this region, rates of CHD are relatively low, and morbidity and mortality from other causes apparently are not increased. In laboratory animals, monounsaturates seemingly do not suppress the immune system or promote oncogenesis. Still, from the discussion of this colloquium, it was apparent that many questions remain unanswered about the metabolic actions of monounsaturated fatty acids, particularly as they compare with other cholesterol-lowering nutrients, and the exchange of ideas among the investigators should stimulate further research on thje metabolic effects of monounsaturated fatty acids.

AB - Monounsaturated fatty acids appear to have many advantages for a cholesterol-lowering diet. They will reduce the plasma LDL level when substituted for saturated fatty acids, and at the same time they will not raise the triglyceride level nor lower the HDL-cholesterol level. Their presence in the diet can enhance palatability for many people. Their value further is supported by their widespread use in the Mediterranean region, where large quantities of olive oil are consumed; in this region, rates of CHD are relatively low, and morbidity and mortality from other causes apparently are not increased. In laboratory animals, monounsaturates seemingly do not suppress the immune system or promote oncogenesis. Still, from the discussion of this colloquium, it was apparent that many questions remain unanswered about the metabolic actions of monounsaturated fatty acids, particularly as they compare with other cholesterol-lowering nutrients, and the exchange of ideas among the investigators should stimulate further research on thje metabolic effects of monounsaturated fatty acids.

UR - http://www.scopus.com/inward/record.url?scp=0023521212&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023521212&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 644

EP - 648

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 6

ER -